Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Irinotecan vs Paclitaxel/Carboplatin/Etoposide in CUP
NCT00193596Phase 3Completed
- Sponsor
- SCRI Development Innovations
- Start
- Sep 2003
- Primary completion
- Sep 2008
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab in carcinoma of unknown primary (CUP), sponsored by SCRI Development Innovations. Started Sep 2003; status: completed.
02
Drugs
gemcitabineirinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab
03
Conditions
carcinoma of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00193596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193596.